Search

everythinglearnresearchcommunity

for

Search:↓

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

Lower SMAD2/3 activation predicts more severe skin cancer.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

CK 19 expression is higher in more severe skin cancers.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Chronic scalp inflammation can turn into cancer, so regular check-ups are important.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Blocking Hedgehog signaling offers new treatment options for advanced basal cell carcinoma.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Scalp melanomas are more dangerous and likely to recur or cause death than other head and neck melanomas.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Inactive hair follicle stem cells help prevent skin cancer.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Many patients on new leukemia drugs had mild to moderate skin reactions.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.